Advertisement

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2022


Monoclonal antibodies are a proven concept in the treatment of cancer and immune disorders, and their promise for both prevention and treatment of infectious diseases is being realized, too. Harnessing this technology has remarkably advanced therapeutic development for COVID-19, underscoring its utility and versatility to rapidly respond to emerging threats to global health or rethink the approach for conditions that are currently challenging to treat. Yet, upscaling the manufacturing process and the considerable price remain a challenge. Those advances come hand-in-hand with educational needs to comprehend technology, pharmacological properties, and recent clinical data. In contrast to existing programs that bring together experts within a specific field, the International Workshop Monoclonal Antibodies for HIV, COVID-19, and Oncology aims to provide a platform for cross-talk of experts from different disciplines that will catalyze knowledge transfer and ultimately move the field forward.

When
November 29 ‐ November 30, 2022
Location
Barcelona, Spain
Venue
Virtual
Link

Map

loading...

GET DIRECTIONS

Advertisement

Hot topics


COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.